Zotefoams PLC Director/PDMR Shareholding (5290T)
March 25 2021 - 8:26AM
UK Regulatory
TIDMZTF
RNS Number : 5290T
Zotefoams PLC
25 March 2021
Zotefoams plc
(the 'Company')
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
25 March 2021 - On 24 March 2021, the Company received notice
from its Employee Benefit Trust of the exercise and partial sale
for tax of nil cost options granted over ordinary shares of 5 pence
each ('Shares') under the Company's Deferred Bonus Share Plan
('DBSP') by Dr K D Hewson as follows:
Total number of Number of shares Aggregated
shares sold sold for tax Sale price
(GBP)
16,270 7664 GBP4.29
----------------- ------------
Awards granted under the DBSP usually vest three years from
grant, subject to satisfaction of service conditions. However,
given the unprecedented circumstances brought about by COVID-19,
and the decision of the Board not to recommend a final dividend for
the year ended 31 December 2019, the proportion of the bonus that
would normally have been paid in cash was deferred into shares (the
'Deferred Bonus proportion'). The Remuneration Committee has now
approved the exercise of the Deferred Bonus proportion taking place
prior to 20 April 2023. The proportion of the bonus that would
normally be deferred into shares (25%) will continue as normal and
will be released after three years.
The award was increased to reflect the dividend paid during the
restricted period.
The Notification of Dealing Form can be found below.
This announcement is made in accordance with the requirements of
Article 19 of the EU Market Abuse Regulation 596/2014.
Lydia Harratt
Group Company Secretary
Zotefoams plc
020 8664 1600
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular
materials technology delivering optimal material solutions for the
benefit of society. Utilising a variety of unique manufacturing
processes, including environmentally friendly nitrogen expansion
for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance
foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses
its own cellular materials to manufacture T-FIT(R) advanced
insulation for demanding industrial markets. Zotefoams also owns
and licenses patented microcellular foam technology to reduce
plastic use in extrusion applications and for ReZorce(R)
mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional
manufacturing sites in Kentucky, USA and Brzeg, Poland (foam
manufacture) Oklahoma, USA (foam products manufacture and
conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu
Province, China (T-FIT).
www.zotefoams.com
AZOTE(R), ZOTEK(R), ReZorce(R) and T-FIT(R) are registered
trademarks of Zotefoams plc.
ZOTEFOAMS PLC
DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND
THEIR CLOSELY ASSOCIATED PERSONS
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Karl David Hewson
---------------------------------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------
a) Position/status: Senior Executive
---------------------------------------------------------------------
b) Initial notification/Amendment: Initial notification
---------------------------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------
a) Name: Zotefoams plc
---------------------------------------------------------------------
b) LEI: 213800B6P256B5XN8D32
---------------------------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------
a) Description of the financial instrument, type of instrument:
Ordinary shares of 5 pence each
Identification code: GB0009896605
---------------------------------------------------------------------
b) Nature of the transaction: Exercise and sale of shares
under the Deferred Bonus Share Plan
---------------------------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
4.289 16,196
----------
4.33 76
----------
---------------------------------------------------------------------
d) Aggregated information:
Aggregate Price Aggregate Volume Aggregate Total
GBP4.29 16,270 GBP69798.30
----------------- ----------------
---------------------------------------------------------------------
e) Date of the transaction: 24 March 2021
---------------------------------------------------------------------
f) Place of the transaction: XLON
---------------------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEADDSAALFEFA
(END) Dow Jones Newswires
March 25, 2021 09:26 ET (13:26 GMT)
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Apr 2023 to Apr 2024
